The USPSTF Recommendation Statement on Coronary Heart Disease Risk Assessment

被引：0
|
作者：
Glynn, Robert J. [1 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2010年 / 152卷 / 06期
关键词：
CARDIOVASCULAR-DISEASE; PREVENTION; GUIDELINES;
D O I：
10.7326/0003-4819-152-6-201003160-00015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：403 / 403
页数：1
相关论文
共 50 条
  • [41] Primary prevention of coronary heart disease - Integrating risk assessment with intervention
    Grundy, SM
    CIRCULATION, 1999, 100 (09) : 988 - 998
  • [42] RISK ASSESSMENT, ENVIRONMENTAL-FACTORS, AND CORONARY HEART-DISEASE
    FEINLEIB, M
    JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY, 1983, 2 (01): : 91 - 104
  • [43] Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service
    Donyai, Parastou
    Van den Berg, Melandi
    PHARMACY WORLD & SCIENCE, 2009, 31 (06): : 643 - 647
  • [44] PREVALENCE AND INCIDENCE DATA IN ASSESSMENT OF RISK OF CORONARY HEART-DISEASE
    BEAGLEHOLE, R
    HEISS, G
    TYROLER, HA
    CASSEL, JC
    HAMES, CG
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1975, 102 (01) : 55 - 62
  • [45] Risk Method Assessment Of Coronary Heart Disease In Carriers Of Polymorphic Cardiogenic
    Nikitin, Valeriy M.
    Efremova, Olga A.
    Churnosov, Mikhail I.
    Lipunova, Elena A.
    Kamyshnikova, Ludmila A.
    Efremova, Olesya A.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (06): : 3233 - 3238
  • [46] Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service
    Parastou Donyai
    Melandi Van den Berg
    Pharmacy World & Science, 2009, 31 : 643 - 647
  • [47] If Coronary Heart Disease is suspected, the Calcium Score improves the Risk Assessment
    von Knobelsdorff, Florian
    KARDIOLOGIE, 2023, 17 (01): : 1 - 3
  • [48] Assessment of coronary heart disease risk in testicular cancer survivors.
    Palmer, S. C.
    Carver, J.
    Jacobs, L.
    Schmitz, K. H.
    Fung, C.
    Mohler, E.
    Vaughn, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 239S - 239S
  • [49] Role of the metabolic syndrome in risk assessment for coronary heart disease - Commentary
    Kohli, P
    Greenland, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (07): : 819 - 821
  • [50] Coronary heart disease risk assessment in Kocaeli region Turkey.
    Hergenc, G
    Ozsullu, T
    CLINICAL CHEMISTRY, 1998, 44 : A83 - A84
12345